[Research progress on GSDME-mediated cell pyroptosis resulting in GSDME type hearing loss]

Liting Peng1, Xi Wang, Weiqian Wang

  • 1Department of Otolaryngology, Chinese People's Liberation Army Rocket Force Special Medical Center, Beijing 100088, China. mixueer0110@126.com.

Insights

Gasdermin E (GSDME)-mediated pyroptosis is implicated in GSDME-related hearing loss. Understanding this programmed cell death pathway offers insights into treating this condition.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cellular Biology

Background:

  • Pyroptosis is a programmed cell death pathway.
  • Gasdermin family proteins are key mediators of pyroptosis.
  • Anomalous pyroptosis is linked to various pathologies, including hearing loss.

Purpose of the Study:

  • To review the role of GSDME-mediated pyroptosis in GSDME-related hearing loss.
  • To provide insights into potential therapeutic strategies for GSDME-related hearing loss.

Main Methods:

  • Literature review focusing on GSDME, pyroptosis, and hearing loss.
  • Analysis of genetic and molecular mechanisms underlying GSDME-related hearing loss.

Main Results:

  • Gain-of-function variants in the GSDME gene cause GSDME-related hearing loss.
  • GSDME-mediated pyroptosis is a key factor in the pathogenesis of this condition.
  • GSDME-related hearing loss exhibits autosomal dominant inheritance.

Conclusions:

  • GSDME-mediated pyroptosis plays a critical role in GSDME-related hearing loss.
  • Targeting GSDME or pyroptosis pathways may offer therapeutic benefits for hearing loss.

Related Concept Videos